MYRIAD ONCOLOGY Trademark
Trademark Overview
On Thursday, March 6, 2025, a trademark application was filed for MYRIAD ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the MYRIAD ONCOLOGY trademark a serial number of 99070993. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, March 17, 2026. This trademark is owned by Myriad Genetics, Inc.. The MYRIAD ONCOLOGY trademark is filed in the Medical Instrument Products, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical test kit related to oncology comprising specimen collection containers in the nature of tubes for the collection of bodily fluids containing cell-free DNA, printed instructions and test forms, materials for transmitting specimens in the nature of envelopes, cardboard boxes, and plastic bags all in the medical field, and printed user information inserts being forms
Medical testing services related to oncology; genetic and genomic testing related to oncology for medical purposes; genetic testing for medical purposes; genetic testing services for diagnostic or treatment purposes; genetic counseling; medical diagnostic testing, monitoring, and reporting services; providing medical diagnostic services, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories and medical diagnostic testing; medical testing, namely, providing reference and clinical laboratory tests that detect, classify, analyze, and evaluate gene mutations, gene variants, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and for use in evaluating and selecting therapy or treatment regimens; medical testing services for evaluating and selecting therapy or treatment regimens, prognosing disease, predicting disease progression or disea...
Providing online publications, namely, questionnaires for medical screening for diagnostic or treatment purposes
Providing temporary use of non-downloadable software for use in medical screening for diagnostic or treatment purposes; Software as a service (SAAS) services featuring software for use in medical screening for diagnostic or treatment purposes
General Information
| Serial Number | 99070993 |
| Word Mark | MYRIAD ONCOLOGY |
| Filing Date | Thursday, March 6, 2025 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, March 17, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 20, 2026 |
Trademark Statements
| Goods and Services | Medical test kit related to oncology comprising specimen collection containers in the nature of tubes for the collection of bodily fluids containing cell-free DNA, printed instructions and test forms, materials for transmitting specimens in the nature of envelopes, cardboard boxes, and plastic bags all in the medical field, and printed user information inserts being forms |
| Goods and Services | Medical testing services related to oncology; genetic and genomic testing related to oncology for medical purposes; genetic testing for medical purposes; genetic testing services for diagnostic or treatment purposes; genetic counseling; medical diagnostic testing, monitoring, and reporting services; providing medical diagnostic services, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories and medical diagnostic testing; medical testing, namely, providing reference and clinical laboratory tests that detect, classify, analyze, and evaluate gene mutations, gene variants, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and for use in evaluating and selecting therapy or treatment regimens; medical testing services for evaluating and selecting therapy or treatment regimens, prognosing disease, predicting disease progression or disease severity, identifying predisposition to developing disease, evaluating the efficacy or toxicity of medical treatments, and identifying risk factors of disease, molecular profiles associated with successful therapies or treatment regimens, and for classifying disease progression or severity; medical diagnostic testing for the detection of cancer to assess the presence or absence of residual disease; health assessment services; providing personalized healthcare and medical information, namely, providing medical information and reports; providing medical information, consultancy and advisory services; health evaluation services, namely, performing health assessments and health screening for purposes of determining medical risks and further testing |
| Goods and Services | Providing online publications, namely, questionnaires for medical screening for diagnostic or treatment purposes |
| Goods and Services | Providing temporary use of non-downloadable software for use in medical screening for diagnostic or treatment purposes; Software as a service (SAAS) services featuring software for use in medical screening for diagnostic or treatment purposes |
| NOT AVAILABLE | "ONCOLOGY" |
Classification Information
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 6, 2025 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 6, 2025 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 6, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 6, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | Wednesday, May 1, 2024 |
| First Use In Commerce Date | Wednesday, May 1, 2024 |
Trademark Owner History
| Party Name | Myriad Genetics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Salt Lake City, UT 84116
US |
| Party Name | Myriad Genetics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Salt Lake City, UT 84116
US |
Trademark Events
| Event Date | Event Description |
| Thursday, March 6, 2025 | NEW APPLICATION ENTERED |
| Thursday, March 6, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 6, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, June 24, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, June 25, 2025 | PRIORITY ACTION WRITTEN |
| Wednesday, June 25, 2025 | PRIORITY ACTION E-MAILED |
| Wednesday, June 25, 2025 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Wednesday, September 24, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 24, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 24, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, October 9, 2025 | FINAL REFUSAL WRITTEN |
| Thursday, October 9, 2025 | FINAL REFUSAL E-MAILED |
| Thursday, October 9, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, December 19, 2025 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Friday, December 19, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 19, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, December 19, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 14, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 20, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 20, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 17, 2026 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
